Malignant Gallbladder Neoplasm — Trials

Malignant Gallbladder Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

201 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 32
Recruiting: 14
Ph III recruiting: 1
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (26)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04068194	Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies	active not recruiting	Phase 1 / Phase 2	103	National Cancer Institute (NCI)NIH	1	Aug 21, 2026	clinicaltrials
NCT03257761	Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer	active not recruiting	Phase 1	55	University of Southern CaliforniaOTHER	1	Jun 1, 2026